Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Changes in RNA levels following inhibition of mechanistic target of rapamycin

ABSTRACT: This study aimed to identify changes in RNA levels after inhibiting the mechanistic target of rapamycin using RNA sequencing.

ORGANISM(S): Homo sapiens

PROVIDER: GSE304701 | GEO | 2025/09/20

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Determination of protein level changes following inhibition of the mechanistic target of rapamycin

Project description:This study aimed to identify changes in protein level after inhibiting the mechanistic target of rapamycin using mass spectrometry analysis

2023-07-27 | PXD041933 | Pride

Changes in RNA levels following inhibition of mechanistic target of rapamycin

Project description:Changes in RNA levels following inhibition of mechanistic target of rapamycin

| PRJNA1302361 | ENA

Assessing protein level changes following inhibition of the mechanistic target of rapamycin

Project description:This study focused on determining changes in protein levels following inhibition of the mechanistic target of rapamycin using mass spectrometry analysis.

2025-09-20 | PXD049052 | Pride

Effects of rapamycin, torin1, and rapalink1 on RNA levels

Project description:This study aimed to identify changes in RNA levels after inhibiting the mechanistic target of rapamycin using RNA sequencing.

2023-07-27 | GSE229623 | GEO

Mechanistic Target of Rapamycin Complex 2 (mTORC2) regulation of the primary human trophoblast cell transcriptome

Project description:Mechanistic Target of Rapamycin Complex 2 (mTORC2) regulation of the primary human trophoblast cell transcriptome

| PRJNA771456 | ENA

Dual inhibition of histone deacetylases and the mechanistic target of rapamycin promotes apoptosis in cell line models of uveal melanoma

Project description:Dual inhibition of histone deacetylases and the mechanistic target of rapamycin promotes apoptosis in cell line models of uveal melanoma

| PRJNA649782 | ENA

Dynamic mRNA gene expression following a rapamycin treatment

Project description:Dynamic mRNA gene expression from the wildtype YSBN6 during a rapamycin treatment (rapamycin-induced downshift). Rapamycin was added to yeast cells growing exponentially on glutamine as sole nitrogen source.

2015-04-07 | GSE54851 | GEO

Untargeted lipid profiling following mTOR inhibition

Project description:<p>The mechanistic target of rapamycin (mTOR) is pivotal in programming cellular lipid homeostasis for the structural and functional integrity of cells. Dysregulation of mTOR and consequent altered lipid metabolism are common features in various diseases, including cancers, making mTOR signaling a promising therapeutic target. Therefore, understanding how mTOR activation and inhibition reprogram cellular lipid homeostasis is of physiological and pathological significance. Using mTOR inhibitors in A375 melanoma cells, we performed untargeted lipid profiling to assess changes in lipid composition following mTOR inhibition.</p>

2025-09-20 | MTBLS12837 | MetaboLights

Inhibition of mechanistic target of rapamycin signaling decreases levels of O-GlcNAc transferase and increases serotonin release in the human placenta.

Project description:Changes in placental function, in particular down-regulation of placental O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT) in response to maternal stress and increased placental secretion of serotonin into the fetal circulation following maternal infection, have been mechanistically linked to adverse neurodevelopment in mice. We hypothesized that mechanistic target of rapamycin (mTOR) signaling is a key regulator of trophoblast serotonin synthesis and OGT protein expression and that serotonin is secreted by the human placenta into the fetal circulation. Placental homogenates (n=46) from elective terminations at 8-22 weeks of gestation and from healthy-term women were sexed and the protein levels of OGT and enzymes involved in serotonin synthesis was determined. Primary human trophoblast (PHT) cells were isolated from normal term placenta (n=27), cultured and transfected (n=8) with siRNA targeting a scramble sequence (control), raptor (inhibits mTOR Complex 1 (mTORC1)), or rictor (inhibits mTOR Complex 2 (mTORC2)). Subsequently, conditioned media and PHT cell lysates were collected. Free serotonin concentration was measured using ELISA in cell culture media and in platelet-depleted normal term umbilical vein and artery plasma (n=38). Both mTORC1 and mTORC2 inhibition down-regulated OGT levels in PHT cells. The level of serotonin synthesis enzyme tryptophan hydroxylase (TPH-1) was higher in early gestation female placentas and at term serotonin concentration was three-fold higher in the umbilical vein than in the umbilical artery. Inhibition of mTORC2, but not mTORC1, increased cultured PHT cell serotonin secretion. Our data are consistent with the model that mTOR signaling is a key regulator of trophoblast serotonin synthesis and OGT protein expression.

| S-EPMC8807024 | biostudies-literature

Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition.

Project description: Not available

| S-EPMC9017755 | biostudies-literature